Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125637372 | 12563737 | 2 | F | 20160713 | 20160716 | 20160818 | PER | US-ASTRAZENECA-2016SE59593 | ASTRAZENECA | 0.00 | M | Y | 136.10000 | KG | 20160818 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125637372 | 12563737 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 80, 4.5 | 21929 | ||||||||||
| 125637372 | 12563737 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 80, 4.5 | 21929 | ||||||||||
| 125637372 | 12563737 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5, 2 PUFFS TWICE A DAY | 21929 | ||||||||||
| 125637372 | 12563737 | 4 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5, 2 PUFFS TWICE A DAY | 21929 | ||||||||||
| 125637372 | 12563737 | 5 | C | AMLODIPINE VESYLATE | 2 | Oral | 0 | 10 | MG | QD | |||||||||
| 125637372 | 12563737 | 6 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 125637372 | 12563737 | 7 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 0 | 2000 | MG | QD | ||||||||
| 125637372 | 12563737 | 8 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | DAILY | 0 | ||||||||||
| 125637372 | 12563737 | 9 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125637372 | 12563737 | 1 | Chronic obstructive pulmonary disease |
| 125637372 | 12563737 | 2 | Emphysema |
| 125637372 | 12563737 | 3 | Chronic obstructive pulmonary disease |
| 125637372 | 12563737 | 4 | Emphysema |
| 125637372 | 12563737 | 5 | Blood pressure abnormal |
| 125637372 | 12563737 | 6 | Gastrooesophageal reflux disease |
| 125637372 | 12563737 | 7 | Eye disorder |
| 125637372 | 12563737 | 8 | Chronic obstructive pulmonary disease |
| 125637372 | 12563737 | 9 | Emphysema |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125637372 | 12563737 | Device malfunction | |
| 125637372 | 12563737 | Drug dose omission | |
| 125637372 | 12563737 | Intentional product misuse | |
| 125637372 | 12563737 | Product taste abnormal | |
| 125637372 | 12563737 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125637372 | 12563737 | 1 | 2015 | 0 | ||
| 125637372 | 12563737 | 2 | 2015 | 0 | ||
| 125637372 | 12563737 | 5 | 2010 | 0 | ||
| 125637372 | 12563737 | 7 | 201509 | 0 |